Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma

MLA

Qu Lin, et al. “Combination of ULK1 and LC3B Improve Prognosis Assessment of Hepatocellular Carcinoma.” Biomedicine & Pharmacotherapy, vol. 97, Jan. 2018, pp. 195–202. EBSCOhost, https://doi.org/10.1016/j.biopha.2017.10.025.

APA

Qu Lin, Zhan-Hong Chen, Jing-Yun Wen, Xing Li, Xiao-Kun Ma, Xiang-Yuan Wu, Dong-Hao Wu, Dan-Yun Ruan, Chang-Chang Jia, & Tian-Tian Wang. (2018). Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy, 97, 195–202. https://doi.org/10.1016/j.biopha.2017.10.025

Chicago

Qu Lin, Zhan-Hong Chen, Jing-Yun Wen, Xing Li, Xiao-Kun Ma, Xiang-Yuan Wu, Dong-Hao Wu, Dan-Yun Ruan, Chang-Chang Jia, and Tian-Tian Wang. 2018. “Combination of ULK1 and LC3B Improve Prognosis Assessment of Hepatocellular Carcinoma.” Biomedicine & Pharmacotherapy 97 (January): 195–202. doi:10.1016/j.biopha.2017.10.025.